维普中文期刊产品整合服务
37篇 您的检索式:作者名="USLU R"
    题名 作者 年代 出处 被引量
1Arsenic trioxide-mediated cytotoxicity and apoptosis in proatate and ovarian carcinoma cell lines显示文摘 Sanli U A Ezgin C 2000Clin Cancer Res2000,6,12:1
2Arsenic trioxide-mediated cytotoxicity and apoptosis in proatate and ovarian carcinoma cell lines显示文摘USLU R SANLI UA SEZGIN C 2000Clin Cancer Res2000,6,12:1
3Evaluation of the turkish ver- sion of the ' ages and stages questionnaires: social-emotional' in i- dentifying children with social-emotional problems显示文摘UCUKER S KAPCI E G USLU R D 2011Infants Young Child2011,24,2:1
4Comparison of laparoscopic and open adrenalectomy显示文摘BULUS H USLU H Y KARAKOYUN R 2013Acta Chir Belg2013,113,3:1
5Arsenic trioxide-mediated cytotoxicity and apoptosis in proatate and ovarian carcinoma cell lines 显示文摘Uslu R Sanli UA Sezgin C 2000Clin Cancer Res2000,6,12:1
6A new approach for determining the length of intervals for fuzzy time series 显示文摘Yolcu U Egrioglu E Uslu V R 2009Applied Soft Computing2009,9,2:1
7A New Approach for Determining the Length of Intervals for Fuzzy Time Series显示文摘Ufuk Yolcu Erol Egrioglu Vedide R Uslu 2009Applied Soft Computing2009,9,2:1
8Gemcitabine treatment in patients with inoperable locally advanced/metastatic pancreatic cancer and prognostic factors显示文摘SEZGIN C KARABULUT B USLU R 2005Scand J Gastroenterol2005,40,12:1
9Bevacizumab + capecitabine as ma- intenance therapy after initial bevacizumab + XELOX treatment in pre- viously untreated patients with metastatic colorectal cancer: phase III Stop and Go'study results - -a Turkish Oncology Group Trial显示文摘Yalcin S Uslu R Dane F 2013On- cology2013,85,6:1
10Bevaeizumab + capecitabine as maintenance therapy after initial bevacizumab + XELOX treatment in previously untreated patients with metastatic colorectal cancer: phase Ill ' Stop and Go' study results - a Turkish Oncology Group Trial显示文摘Yalcin S Uslu R Dane F 2013Oncology2013,85,:1
11Arsenic trioxide-mediated cytotoxicity and apoptosis in prostate and ovarian carcinoma cell lines显示文摘Uslu R Sanli UA Sezgin C 2000Clin Cancer Res2000,6,:1
12Arsenic trioxide-mediated cytotoxicity and apoptosis in prostate and ovarian carcinoma cell lines显示文摘Uslu R Sanli U A Sezgin C et ad 2000Clin Cancer Res2000,6,:1
13Bevacizumab+capecitabine as maintenance therapy after initial bevacizumab+XELOX treat- ment in previously untreated patients with metastatic colorectal cancer: phase Ill 'Stop and Go'study results: a Turkish Qncology Group Trial显示文摘Yalcin S Uslu R Dane F 2013Oncology2013,85,6:1
14WNT1 gene expression alters in heterogeneous population of prostate cancer cells; decreased expression pattern observed in CD133+/CD44+ prostate cancer stem cell spheroids 显示文摘Goksel G Bilir A Uslu R 2014J BUON2014,19,1:1
15Doxazosin: a new cytotoxic agent for prostate cancer显示文摘Cal C Uslu R Gunaydim G 2000Br J Urol2000,85,:1
16Beck Depression Inventory Ⅱ:evaluation of the psychometric properties and cut-off points in a Turkish adult population显示文摘Kapci EG Uslu R Turkcapar H 2008Depress Anxiety2008,25,10:1
17Serum HER-2/neu and surviving levels and their relationship to histological Parameters in early-stage breast cancer显示文摘Goksel G Taneli F Uslu R 2007J Int Med Res2007,35,2:1
18Arsenic trioxide-mediated cytotoxicity and apoptosis in prostate and ovarian carcinoma cell lines显示文摘Uslu R Sanli UA Sezgin C 2000Clin Cancer Res2000,6,:1
19Comparison of la- paroscopic and open adrenalectomy显示文摘Bulus H Uslu H Y Karakoyun R 2013Acta Chir Belg2013,113,3:1
20Gemcitabine treat- ment in patients with inoperable locally advanced metastat- ic pancreatic cancer and prognostic factors 显示文摘Sezgln C Karabulut B Uslu R 2005Scand J Gastroentero12005,40,12:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费